NMR and MD studies combined to elucidate inhibitor and water interactions of HIV-1 protease and their modulations with resistance mutations
- PMID: 31243634
- PMCID: PMC6941145
- DOI: 10.1007/s10858-019-00260-6
NMR and MD studies combined to elucidate inhibitor and water interactions of HIV-1 protease and their modulations with resistance mutations
Abstract
Over the last two decades, both the sensitivity of NMR and the time scale of molecular dynamics (MD) simulation have increased tremendously and have advanced the field of protein dynamics. HIV-1 protease has been extensively studied using these two methods, and has presented a framework for cross-evaluation of structural ensembles and internal dynamics by integrating the two methods. Here, we review studies from our laboratories over the last several years, to understand the mechanistic basis of protease drug-resistance mutations and inhibitor responses, using NMR and crystal structure-based parallel MD simulations. Our studies demonstrate that NMR relaxation experiments, together with crystal structures and MD simulations, significantly contributed to the current understanding of structural/dynamic changes due to HIV-1 protease drug resistance mutations.
Keywords: Crystal structures; Drug design; HIV-1; Inhibitor; MD; NMR; Protease.
Figures
Similar articles
-
Characterizing early drug resistance-related events using geometric ensembles from HIV protease dynamics.Sci Rep. 2018 Dec 18;8(1):17938. doi: 10.1038/s41598-018-36041-8. Sci Rep. 2018. PMID: 30560871 Free PMC article.
-
Exploring the drug resistance mechanism of active site, non-active site mutations and their cooperative effects in CRF01_AE HIV-1 protease: molecular dynamics simulations and free energy calculations.J Biomol Struct Dyn. 2019 Jul;37(10):2608-2626. doi: 10.1080/07391102.2018.1492459. Epub 2019 Jan 10. J Biomol Struct Dyn. 2019. PMID: 30051758
-
Exploring the drug resistance of V32I and M46L mutant HIV-1 protease to inhibitor TMC114: flap dynamics and binding mechanism.J Mol Graph Model. 2015 Mar;56:60-73. doi: 10.1016/j.jmgm.2014.11.003. Epub 2014 Dec 5. J Mol Graph Model. 2015. PMID: 25562662 Free PMC article.
-
Structural and thermodynamic basis of resistance to HIV-1 protease inhibition: implications for inhibitor design.Curr Drug Targets Infect Disord. 2003 Dec;3(4):311-28. doi: 10.2174/1568005033481051. Curr Drug Targets Infect Disord. 2003. PMID: 14754432 Review.
-
Inhibitors of HIV-1 protease: a major success of structure-assisted drug design.Annu Rev Biophys Biomol Struct. 1998;27:249-84. doi: 10.1146/annurev.biophys.27.1.249. Annu Rev Biophys Biomol Struct. 1998. PMID: 9646869 Review.
Cited by
-
Gibbs Free Energy Calculation of Mutation in PncA and RpsA Associated With Pyrazinamide Resistance.Front Mol Biosci. 2020 Apr 9;7:52. doi: 10.3389/fmolb.2020.00052. eCollection 2020. Front Mol Biosci. 2020. PMID: 32328498 Free PMC article.
-
Integrative methods in structural biology.J Biomol NMR. 2019 Jul;73(6-7):261-263. doi: 10.1007/s10858-019-00267-z. J Biomol NMR. 2019. PMID: 31313058 No abstract available.
-
Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond.Chem Rev. 2021 Mar 24;121(6):3238-3270. doi: 10.1021/acs.chemrev.0c00648. Epub 2021 Jan 7. Chem Rev. 2021. PMID: 33410674 Free PMC article. Review.
-
Viral proteases: Structure, mechanism and inhibition.Enzymes. 2021;50:301-333. doi: 10.1016/bs.enz.2021.09.004. Epub 2021 Nov 17. Enzymes. 2021. PMID: 34861941 Free PMC article.
-
Analysis of the Structural Dynamics of Proteins in the Ligand-Unbound and -Bound States by Diffracted X-ray Tracking.Int J Mol Sci. 2023 Sep 6;24(18):13717. doi: 10.3390/ijms241813717. Int J Mol Sci. 2023. PMID: 37762021 Free PMC article. Review.
References
-
- Altman MD, Ali A, Reddy GS, Nalam MN, Anjum SG, Cao H, Chellappan S, Kairys V, Fernandes MX, Gilson MK, Schiffer CA, Rana TM & Tidor B (2008). HIV-1 protease inhibitors from inverse design in the substrate envelope exhibit subnanomolar binding to drug-resistant variants. J Am Chem Soc 130: 6099–113. - PMC - PubMed
-
- Baldwin ET, Bhat TN, Gulnik S, Liu B, Topol IA, Kiso Y, Mimoto T, Mitsuya H & Erickson JW (1995). Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatine. Structure 3: 581–590. - PubMed
-
- Bandyopadhyay P & Meher BR (2006). Drug resistance of HIV-1 protease against JE-2147: I47V mutation investigated by molecular dynamics simulation. Chem Biol Drug Des 67: 155–61. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
